Location: Boston MA, Tampa FL, Fort Wayne IN, St Louis MO,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06697184
Phase1, Phase2, Recruiting
The CARDIOPROTECT Trial
for
Diffuse Large B-cell Lymphoma (DLBCL), Cardiotoxicity, Lymphoma
Location: Boston MA
Sponsor: Beth Israel Deaconess Medical Center
Sex: All
Age: 18+
Code: NCT07654426
Phase2, Recruiting
NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma
for
Relapsed Neuroblastoma, Refractory Neuroblastoma,
Location: Houston TX
Sponsor: Baylor College of Medicine
Sex: All
Age: 1 - 24
Code: NCT07211737
Phase1, Recruiting
Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT05672251
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
for
Lymphoma, Non-Hodgkin, Lymphoma, Follicular,
Location: Toronto, Nashville TN, Denver CO
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07519772
Phase1, Phase2, Recruiting
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
for
Acute Adult T-Cell Leukemia/Lymphoma,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04301076
Phase1, Recruiting
Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma
for
Recurrent Plasmablastic Lymphoma,
Location: Pittsburgh PA, Duarte CA, Orange CA, Irvine CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07332507
Phase1, Recruiting
Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma
for
T-cell Acute Lymphoblastic Leukemia, Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 12 - 30
Code: NCT07513129
Phase1, Recruiting
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
for
Chronic Lymphocytic Leukemia (CLL),
Location: Boston MA, Durham NC, Winston-Salem NC, Charlotte NC
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07024706
Phase2, Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer